Menu
Intsel Chimos is your future a partner, dedicated to ensuring early access to innovative therapies and to supporting patients with rare disease.
As a distinguished distributor and operator of
compassionate and/or early access medicines
(AAC/AAP), we provide solutions to patients whose
needs are unmet by currently available French
treatments.
Intsel Chimos has acquired in-depth knowledge of and
familiarity with the French and European healthcare
systems. We are fully dedicated to supporting our
parthers in navigating these systems successfully across
all therapeutic areas.
Intsel Chimos has developed expertise that allows it to
be reactive and flexible in the acquisition and
distribution or various pharmaceutical specialties to
hospitals and retail pharmacies.
As a pharmaceutical company, Intsel Chimos is committed to supporting our partners’ success at all stages : registration, marketing, and commercialization of drugs. We aim to accomplish this in the simplest and most efficient way possible, while maintaining strict compliance with the French and European regulations.